Evidence map›Paper›PMID 34285193›Full record

ArticleCell death & disease2021

High-throughput sequencing identified circular RNA circUBE2K mediating RhoA associated bladder cancer phenotype via regulation of miR-516b-5p/ARHGAP5 axis.

Chen Yang, Zezhong Mou, Siqi Wu, Yuxi Ou, Zheyu Zhang, Xinan Chen, Xiyu Dai, Chenyang Xu, Shanhua Mao, Haowen Jiang

Erratum issuedAbstract read
In one paragraph

Article in Cell death & disease, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. The roles and mechanisms of circular RNAs related to mTOR in cancers.Journal of clinical laboratory analysis · 2022
    Review
  12. Article
  13. Exosome-derived circTRPS1 promotes malignant phenotype and CD8+ T cell exhaustion in bladder cancer microenvironments.Molecular therapy : the journal of the American Society of Gene Therapy · 2022
    Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Chen Yang *Department of Urology, Huashan Hospital, Fudan University, Shanghai, China. YangC_Huashan@163.com.
Zezhong Mou *Department of Urology, Huashan Hospital, Fudan University, Shanghai, China.
Siqi Wu *Department of Urology, Huashan Hospital, Fudan University, Shanghai, China.
Yuxi OuDepartment of Urology, Huashan Hospital, Fudan University, Shanghai, China.
Zheyu ZhangDepartment of Urology, Huashan Hospital, Fudan University, Shanghai, China.ORCID http://orcid.org/0000-0003-1907-0765
Xinan ChenDepartment of Urology, Huashan Hospital, Fudan University, Shanghai, China.
Xiyu DaiDepartment of Urology, Huashan Hospital, Fudan University, Shanghai, China.
Chenyang XuDepartment of Urology, Huashan Hospital, Fudan University, Shanghai, China.
Shanhua MaoDepartment of Urology, Huashan Hospital, Fudan University, Shanghai, China. maoshanhua@163.com.
Haowen JiangDepartment of Urology, Huashan Hospital, Fudan University, Shanghai, China. haowj_sh@fudan.edu.cn.ORCID http://orcid.org/0000-0002-5349-1363

Funding

National Natural Science Foundation of China (National Science Foundation of China) 81802569National Natural Science Foundation of China (National Science Foundation of China) 82071703
6 · The paper itself

Abstract

Bladder cancer (BC) is known as a common and lethal urinary malignancy worldwide. Circular RNAs (circRNAs), an emerging non-coding RNA, participate in carcinogenesis process of several cancers including BC. In this study, high-throughput sequencing and RT-qPCR were applied to discover and validate abnormal high expression of circUBE2K in BC tissues. Fluorescence in situ hybridization (FISH) was used to detect hsa_circ_0009154 (circUBE2K) expression and subcellular localization in BC tissues. High circUBE2K predicted unfavorable prognoses in BCs, as well as correlated with clinical features. CCK8, transwell, EdU and wound healing assays demonstrated down-regulating circUBE2K decreased BC cell phenotype as proliferation, invasion, and migration, respectively. Further studies showed that circUBE2K promoted BC progression via sponging miR-516b-5p and enhancing ARHGAP5 expression through regulating RhoA activity. Dual-luciferase reporter, FISH and RNA pulldown assays were employed to verify the relationships among circUBE2K/miR-516b-5p/ARHGAP5/RhoA axis. Down-regulating miR-516b-5p or overexpressing ARHGAP5 restored RhoA activity mediated BC cell properties after silencing circUBE2K. Subcutaneous xenograft and metastasis model identified circUBE2K significantly increased BC cell metastasis and proliferation in-vivo. Taken together, we found that circUBE2K is a tumor-promoting circRNA in BC that functions as a ceRNA to regulate ARHGAP5 expression via sponging miR-516b-5p.

Indexed as

Gene Expression Regulation, NeoplasticHigh-Throughput Nucleotide SequencingBase SequenceCell Line, TumorCell MovementCell ProliferationDown-RegulationEpithelial-Mesenchymal TransitionGene SilencingGTPase-Activating ProteinsHumansMicroRNAsNeoplasm InvasivenessNeoplasm MetastasisPhenotypePhosphorylationARHGAP5 protein, humanGTPase-Activating ProteinsMicroRNAsMIRN516 microRNA, humanProto-Oncogene Proteins c-aktrhoA GTP-Binding ProteinRNA, CircularTransforming Growth Factor beta

Identifiers

PMID34285193
PMCPMC8292476

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.